Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products
CJEU Advocate General on Distributors’ Obligations for Medical Devices
by multiple authors
by multiple authors
by Irina Rebin
by Irina Rebin
by Kerstin Bär, LL.M. (Bristol, UK) and Donata Freiin von Enzberg, LL.M.